SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $28,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paloma Partners Management Co | 3,775,000 | $1,359,000 | 0.05% |
| Oaktree Fund Advisors, LLC | 66,000 | $23,760 | 0.02% |
| GoalVest Advisory LLC | 32,915 | $11,849 | 0.01% |
| Houlihan Financial Resource Group, Ltd. | 30,000 | $11 | 0.01% |
| Granite Bay Wealth Management, LLC | 22,520 | $8 | 0.01% |
| S&T BANK/PA | 38,853 | $14 | 0.00% |
| Lattice Capital Management, LLC | 51,800 | $18,648 | 0.00% |
| Modus Advisors, LLC | 19,706 | $7,094 | 0.00% |
| Crescent Grove Advisors, LLC | 60,000 | $21,600 | 0.00% |
| SlateStone Wealth, LLC | 21,433 | $8 | 0.00% |